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Additional results 
Selecting cysteine-less variant of ClyA 
Since we desired to obtain a cysteine-less ClyA variant amenable to site-specific 
chemical modification, we subjected ClyA-CS to saturation mutagenesis at position 87 
and screened the resulting library. Fixation pattern from previous rounds suggested that 
clones containing cysteine 87 would show highest activity; therefore, we have isolated 
and sequenced 12 clones corresponding to medium to high hemolytic activity in the 
crude lysates. Expectedly, the most active clones contained cysteine at position 87, 
however, three variants C87A, C87S, C87T with ~10 fold less activity than ClyA-CS did 
not. ClyA-CS C87A variant, which also displayed an additional mutation H307Y in the 
His-Tag, was subjected for an additional 5th round of directed evolution. This mutant was 
chosen because it oligomerized well, formed nanopores that remained open at -150 mV 
and the codon encoding for the alanine at position 87 could not convert to cysteine via 
single mutation. 
 
Additional discussion 
Electrical Stability of ClyA variants 
In planar lipid bilayers two parameters were considered when selecting ClyA 
variants: low background noise and the absence of gating events. The former could be 
easily characterized by the power spectrum of a current trace (Figure 4c). The latter 
could be described as transient or permanent variations in the open pore current 
(gating), which is most likely due to the spontaneous opening and closing of the 
nanopore. When the gating event was permanent, flipping the applied potential to 
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positive and negative values usually restored the open pore current IO, although for 
Type III ClyA-CS this was not always possible (Figure S3b). Different batches of 
proteins showed consistent background noise but inconsistent gating. Typically, below -
150 mV Type I ClyA-CS showed less than one gating event per minute while Type II 
ClyA-CS gated slightly more. Type III ClyA-CS on the other hand could only be used up 
to ~ -35 mV and even then it often closed to a state of lower conductance that could not 
be reverted (Figure S3b). Interestingly, at positive applied potentials ClyA was less 
stable than at negative applied potentials (Figure S3a). Different gating probabilities at 
opposite applied potentials are often observed with biological nanopores, for example, 
DHL1  and MspA2 nanopores often gate at negative but not at positive applied 
potentials. Conveniently, however, proteins enter the cis vestibule of ClyA at negative 
applied potentials3 and they could thus be sampled up to -150 mV. The factors that 
influence the entry of analytes into a nanopore are passive diffusion, the applied 
potential and electroosmosis. By analogy to  solid-state nanopores with a negatively 
charged internal surface,4 electroosmosis is the most likely dominant force driving HT 
into ClyA nanopores.3 This is shown by the fact that proteins despite their charge enter 
the ClyA pore only at negative applied potentials3 where the electroosmotic flow from 
cis to trans is strong (ClyA nanopores are cation selective5). 
 
Variation in the dwell time values for HT current blockades 
We recurrently observed large variations in HT blockade life times for both Type I 
and Type II ClyA-CS (Figure S4a). We think this might be due to small differences in the 
folding of ClyA. Although there are no strong evidences, this interpretation is supported 
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by the observation that in rare occasions individual ClyA nanopores switched between 
two substates with slightly different (higher or lower) open pore current (IO and IO’  inset  
in Figure S4d) and showing different dwell times for HT induced current blockades 
(Figure S4d). Crucially, the existence of multiple configurations of the trans-vestibule 
does not conflict with our interpretation that ClyA might assemble in multiple oligomer 
states. This is because the differences in the IO and IO’  (ΔI  =  4  pA  at  -150 mV) are tiny 
compared to the difference in the open pore currents measured for Type I and Type II 
ClyA-CS (ΔI   =   55   pA   at   -150 mV, Figure S4d) and the IRES% values of the current 
blockades remained largely unaffected (See variation of measured values in Figure S4a 
versus Figure S4b). In addition, despite the dwell time variations are large, the life times 
of HT blockades to Type I ClyA-CS were always distinguishable from the life times of 
HT blockades to Type II ClyA (Figure S4a).  
 
Folded vs unfolded translocation 
We assume that while in the vestibule of ClyA, HT is folded under all applied 
potentials. We base our interpretation on the analysis of the voltage dependence of the 
residual blocked pore current (IRES%, Figure S4b). When a molecule is lodged within the 
lumen of a nanopore, the ionic current block is proportional to the atomic volume of the 
electrolytes being excluded by the molecule.6-10 Therefore, if the molecule remains 
folded under different applied voltages, the IRES% should remain constant. By contrast, if 
a protein unfolds the IRES% is expected to change, giving that the length and surface 
area of the unfolded polypeptide chain is different to that of the globular protein. 
Therefore, since the residual current of the L2 level of HT blockades remains constant 
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over the entire potential range considered (Figure S4b) it suggests that HT remains 
folded while lodged within ClyA-CS.  
However, in about 50% of the current blockades to Type I ClyA-CS from -110 to -
150 mV, and in less than 10% of the blockades to Type II ClyA-CS nanopores from -90 
to -150 mV, the HT current blockades terminated with an additional current level (spike) 
higher than the open nanopore current (Figure S5). This current spike might be 
associated to the translocation of the (partially) unfolded HT polypeptide chain through 
the transmembrane region of ClyA, similar to the transient current increase that is also 
observed for the translocation of DNA through solid-state nanopores at 150 mM KCl11 or 
for the electrophoretic translocation of DNA through carbon nanotubes.12 This 
explanation however is not very likely considering the additional ionic current observed 
in the DNA translocation experiments is most likely due to the counterions associated 
with the negative charges in DNA,11 while the charge density of  a polypeptide chain is 
much lower than that of DNA. In addition, the diameter of the trans vestibule of ClyA is 
relatively large, and protein domains should be able to translocate through ClyA (main 
text). A more likely explanation is that the D-helices of the transmembrane domain of the 
ClyA nanopores transiently change conformation allowing the translocation of HT 
through the pore. 
 
 
Materials  
Unless otherwise specified chemicals were purchased from Sigma-Aldrich, DNA 
from Integrated DNA Technologies (IDT), enzymes from Fermentas and lipids from 
S6 
 
Avanti Polar Lipids. The concentration of human thrombin was calculated from its unit 
concentrations, assuming that 1 NIH unit/mL = 10 nM. All errors are given as standard 
deviations. During protein characterization experiments, purified ClyA oligomers were 
stored at 4°C for several weeks in 0.2% n-Dodecyl-beta-D-Maltoside (DDM) and 5 mM 
EDTA. Alternatively, we found that ClyA nanopores could be stored for several months 
at 4°C in excised BN-PAGE gel bands. 
 
Methods 
Construction of ClyA libraries by error-prone PCR 
Libraries were constructed by amplifying the ClyA genes from plasmid DNA using 
T7 promoter and T7 terminator primers (Table S2). In the first mutagenesis round we 
used as a template a plasmid containing the synthetic gene encoding for ClyA-SS from 
Salmonella Typhi(GenScript). From the second mutagenesis round we used the DNA 
plasmids that were derived from the previous round of selection. In ClyA-SS, the WT 
sequence was modified by the substitution of the two Cys residues (positions 87 and 
285) with Ser and by the attachment of a DNA encoding a Gly-Ser-Ser linker followed 
by a C-terminal hexahistidine tag.3 
DNA amplification was performed by error prone PCR: 400 PL of final PCR mix  
(200 µl of REDTaq ReadyMix, 8 PM final concentration of forward and reverse primers, 
~400 ng of plasmid template and ddH2O up to 400 Pl) was split into 8 reaction mixtures 
containing 0-0.2 mM of MnCl2 and cycled for 27 times (pre-incubation at 95ºC for 3 min, 
then cycling: denaturation at 95ºC for 15 s, annealing at 55ºC for 15 s, extension at 
72ºC for 3 min). These conditions typically yielded 1-4 mutations per gene in the final 
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library. The PCR products were pooled together, gel purified (QIAquick Gel Extraction 
Kit, Qiagen) and cloned into a pT7 expression plasmid (pT7-SC1) by MEGAWHOP 
procedure:13 ~500 ng of the purified PCR product was mixed with ~300 ng of ClyA-SS 
circular DNA template and the amplification was carried out with Phire Hot Start II DNA 
polymerase (Finnzymes) in 50 µL final volume (pre-incubation at 98ºC for 30s, then 
cycling: denaturation at 98ºC for 5 s, extension at 72ºC for 1.5 min for 30 cycles). The 
circular template was eliminated by incubation with Dpn I (1 FDU) for 2 hr at 37ºC. The 
resulted mixture was desalted by dialysis against agarose gel (2.5 % agarose in Milli-Q 
water) and transformed into E. cloni® 10G cells (Lucigen) by electroporation. The 
transformed bacteria were grown overnight at 37ºC on ampicillin (100 µg/ml) LB agar 
plates typically resulting in >105 colonies, and were harvested for library plasmid DNA 
preparation.  
 
Construction of saturation mutagenesis library at position 87 of evolved 
ClyA 
In order to construct a library containing cysteine–free ClyA variants, the gene 
encoding for 4ClyA4 (ClyA-CS, Table S1) was amplified using the 87NNS primer 
(containing a degenerate codon at position 87 encoding for the complete set of amino 
acids, Table S2) and T7 terminator primers. PCR conditions: 0.3 mL final volume of 
PCR mix (ReadyMix™), containing ~400 ng of template plasmid, cycled for 30 times 
(pre-incubation at 95ºC for 3 min, then cycling: denaturation at 95ºC for 15 s, annealing 
at 55ºC for 15 s, extension at 72ºC for 3 min). The resulting PCR product was cloned 
S8 
 
into pT7 expression plasmid by MEGAWHOP procedure using 4ClyA4 circular template 
(see above). 
 
Construction of the ClyA-WT 
ClyA-SS gene was amplified using 87C and 285C primers (Table S2). PCR 
conditions: 0.3 mL final volume of PCR mix (150 µl of REDTaq ReadyMix, 6PM of 
forward and reverse primers, ~400 ng of template plasmid), cycled for 27 times (pre-
incubation at 95ºC for 3 min, then cycling: denaturation at 95ºC for 15 s, annealing at 
55ºC for 15 s, extension at 72ºC for 3 min). The resulting PCR product was cloned into 
pT7 expression plasmid by the MEGAWHOP procedure described above, using ClyA-
SS circular template. 
 
Screening of ClyA libraries and hemolytic assay  
Since ClyA-SS displays "border of detection" hemolytic activity, during the first two 
rounds of the mutagenesis libraries were only screened for activity on Brucella Agar 
with 5% Horse Blood. From the third selection round, colonies displaying hemolytic 
activity on Brucella Agar were further screened for hemolytic activity on horse 
erythrocytes from the crude lysate after overexpression. The goal of this work was to 
obtain ClyA variants that oligomerised well in DDM and formed nanopores with low 
electrical noise and uniform unitary conductance in lipid bilayers. Therefore, screening 
for hemolytic activity alone could not serve as the sole criteria for selection of such 
variants (for example WT-ClyA is very hemolytically active, but showed non-uniform 
unitary current distribution). Thus, from the 4th round, proteins from the crude lysate 
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were purified by Ni-NTA affinity chromatography and the oligomerisation of ClyA was 
tested on BN-PAGE after incubation in DDM. ClyA nanopores that oligomerised well 
were then tested in planar lipid bilayers (with particular stress on uniformity of formed 
channels, low electrical noise and stability at high applied potentials). 
 
Screening for Hemolytic activity on Brucella horse blood agar plates 
After the plasmid DNA was electroporated into E. cloni® EXPRESS BL21 (DE3) cells 
(Lucigen), transformants were prescreened on Brucella Agar with 5% Horse Blood 
(BBL™, Becton, Dickinson and Company) supplemented with 100 µg/ml ampicillin. 
Clones displaying hemolytic activity, which was observed by a lytic aura around the 
colonies after overnight growth at 37 ºC, were individually grown in 96-deep-wells plates 
overnight by shaking at 37ºC (0.5 mL 2xYT medium containing 100µg/mL ampicillin). 
The obtained cultures were either pooled for preparation of plasmid DNA (QIAprep, 
Qiagen) that served as a template for the next round (rounds 1 and 2), or used as 
starters for protein overexpression (rounds 3 to 5).  
 
Screening for hemolytic activity in crude lysates after ClyA overexpression 
Rounds 3 to 5: 50 Pl of the starter cultures from 400-600 clones (see above) were 
inoculated into 450 Pl of fresh medium in new 96-deep-wells plates and the cultures 
were grown at 37ºC until OD600~0.8. Then IPTG (0.5 mM) was added to induce 
overexpression, and the temperature was reduced to 25ºC for an overnight incubation. 
Next day, bacteria were harvested by centrifugation at 3000 x g for 15 min at 4ºC, the 
supernatant was discarded and pellets were incubated at -70ºC for few a hours to 
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facilitate cell disruption. Then pellets were resuspended in 0.3 mL of lysis  buffer (15 mM 
Tris.HCl pH 7.5, 150 mM NaCl, 1 mM MgCl2, 10 µg/ml lysozyme and 0.2 units/mL 
DNAse I) and lysed by shaking at 1300 RPM for 30 min at 37   ºC. 5-30 µL of lysates 
were then added to 100 uL of ~1% horse erythrocytes suspension. The latter was 
prepared by centrifuging horse blood (bioMérieux) at 6000 x g for 5 min at 4 ºC, the 
pellet was resuspended in 15 mM Tris.HCl pH 7.5, 150 mM NaCl (If the supernatant 
showed a red color, the solution was centrifuged again and the pellet resuspended in 
the same buffer). The hemolytic activity was monitored by the decrease in OD at 650nm 
over time (~3-10 min intervals, measured using Multiskan GO Microplate 
Spectrophotometer, Thermo Scientific).  
 
Screening for oligomerization and nanopore formation of evolved variants 
Rounds 4-5: 6-12 of the most hemolytically active variants were partially purified from 
the same lysates that were used for the screening of hemolytic activity by using Ni-NTA 
affinity chromatography: 0.2 mL of crude lysate containing monomeric ClyA was brought 
to 1 mL with 15 mM Tris.HCl pH 7.5, 150 mM NaCl supplemented with 1% DDM (to 
trigger ClyA oligomerization) and 10 mM imidazole, incubated at ambient temperature 
for 20 min and centrifuged at 20,000 x g for 10 min at 4ºC. The clarified lysates were 
allowed to bind to 20 µL (bead volume) of Ni-NTA agarose beads (Qiagen) for 1 hr by 
gentle mixing at 4ºC. The unbound fraction was removed by centrifugation at 20,000 x g 
for 10 min at 4ºC (the supernatant was discarded). Finally, oligomerized ClyA proteins 
were eluted with 50 PL of 600 mM imidazole in 15 mM Tris.HCl pH 7.5 150 mM NaCl 
0.2% DDM. Typically ~40 Pg of ClyA was supplemented with ~10% glycerol and 1x of 
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NativePAGETM Running Buffer and 1x Cathode Buffer Additive (InvitrogenTM) and then 
loaded on BN-PAGE (Figure S2). Variants that formed oligomers on BN-PAGE were 
then tested in planar lipid bilayers (with particular stress on uniformity of formed 
channels).  
 
Protein overexpression and purification 
E. cloni® EXPRESS BL21 (DE3) cells were transformed with the pT7 plasmids 
containing the ClyA gene. Transformants were selected by growth overnight at 37ºC on 
LB agar plates supplemented with 100 mg/L ampicillin. The resulting colonies were 
inoculated into LB medium containing 100 mg/L of ampicillin. The culture was grown at 
37ºC, with shaking at 200 rpm, until it reached an OD600 of 0.6 to 0.8. The expression of 
ClyA was then induced by the addition of 0.5 mM IPTG and the growth was continued at 
20ºC. The next day the bacteria were harvested by centrifugation at 6000 x g for 10 min 
and the pellets were stored at -70ºC. 
The pellets(originated from 50 ml culture)  containing monomeric ClyA were thawed and 
resuspended in 20 mL of wash buffer (10 mM imidazole, 150 mM NaCl, 15 mM 
Tris.HCl, pH 7.5), supplemented with 1 mM MgCl2 and 0.05 units/mL of DNAse I and 
the bacteria were lysed by sonication. The crude lysates were clarified by centrifugation 
at 6000 x g for 20 min and the supernatant was mixed with 200 PL of Ni-NTA resin 
(Qiagen) in wash buffer. After 1 hr, the resin was loaded into a column (Micro Bio Spin, 
Bio-Rad) and washed with ~5 ml of the wash buffer. ClyA was eluted with approximately 
~0.5 mL of wash buffer containing 300 mM imidazole. Protein concentration was 
determined by Bradford assay and the purified proteins were stored at 4ºC. 
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Construction of ClyA models  
The 13mer and 14mer ClyA nanopores were modeled from the 12mer of the crystal 
structure (PDB code: 2WCD) as follow: A central axis was constructed through the 
length of the 12mer (ax12), and the distance between the C-alpha atom of residue 114 
in the monomer A (114Ca-A) and the ax12 was measured giving the approximate radius 
of the pore (r12). The distance (d) between the 114Ca-A and the equivalent atom in 
monomer B (114Ca-B) was used to calculate the approximate circumference of the 
12mer (c12 = d x 12), 13mer (c13 = d x 13) and 14mer (c14 = d x 14). The radius of the 
three oligomers (r12, r13 and r14) was then calculated from the circumference using 
simple trigonometry. The 12mer, 13mer and 14mer were then built by placing the 
monomers at distances r12, r13 and r14, respectively, from the central ax and rotated 
over an angle of 360°/12, 360°/13 and 360°/14, respectively. The 12mer that was built 
using this method reproduced perfectly the 12mer of the X-ray crystal structure 
(RMS=0.29 Å), showing the high degree of symmetry and feasibility to construct higher 
order pores.14  
The size of the nanopore opening was determined by increasing the Van der 
Waals radii of the atoms of ClyA until the pore closed. Then the increased value of the 
Van der Waals radii was taken as the radius of the pore. The diameter of thrombin was 
calculated from a sphere corresponding to the measured molecular volume of the 
protein.14  
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Electrical recordings in planar lipid bilayers 
The applied potential refers to the potential of the trans electrode. ClyA nanopores were 
inserted into lipid bilayers from the cis compartment, which was connected to the 
ground. The two compartments were separated by a 25-Pm thick 
polytetrafluoroethylene film (Goodfellow Cambridge Limited) containing an orifice ~100 
Pm in diameter. The aperture was pretreated with ~5 PL of 10% hexadecane in pentane 
and a bilayer was formed by the addition of ~10 µL of 1,2-diphytanoyl-sn-glycero-3-
phosphocholine (DPhPC) in pentane (10 mg/mL) to both electrophysiology chambers. 
Typically, the addition of 0.01-0.1 ng of oligomeric ClyA to the cis compartment (0.5 mL) 
was sufficient to obtain a single channel. ClyA nanopores displayed a higher open pore 
current at positive than at negative applied potentials, which provided a useful tool to 
determine the orientation of the pore. Electrical recordings were carried out in 150 mM 
NaCl, 15 mM Tris.HCl pH 7.5. The temperature of the recording chamber was 
maintained at 28°C by water circulating through a metal case in direct contact with the 
bottom and sides of the chamber.  
 
Data recording and analysis 
Electrical signals from planar bilayer recordings were amplified by using an Axopatch 
200B patch clamp amplifier (Axon Instruments) and digitized with a Digidata 1440 A/D 
converter (Axon Instruments). Data were recorded by using Clampex 10.2 software 
(Molecular Devices) and the subsequent analysis was carried out with Clampfit software 
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(Molecular Devices). Open pore currents and HT blockades were recorded by applying 
a 10 kHz low-pass Bessel filter and sampling at 50 kHz if not otherwise stated. For 
unitary channel conductance distributions data collection, traces were further filtered 
digitally with Gaussian low-pass filter with 200 Hz cutoff. The open pore currents were 
determined for all inserted channels at both +35 and -35 mV to ensure that the pore 
inserted with the correct orientation and values corresponding to -35 mV were used to 
construct the distributions. Open pore current values (IO) for ClyA and blocked pore 
current values (IB) for HT were calculated from Gaussian fits to all points histograms 
(0.3 pA bin size).3 Histograms for HT blockades were prepared from at least 10 current 
blockades at least 0.5 s long. The residual current values (IRES%) were calculated as: 
IRES% = IB / IO %. When HT produced two current levels within the same blockade, their 
relative contributions (Figure 5a, Table 1) were deduced from the area of the peaks 
obtained from Gaussian fits to the all points histogram.3 HT blockade lifetimes were 
calculated by single exponential fitting of the cumulative distribution of at least 200 
current blockades (Figure S7). Graphs were made with Origin (OriginLab Corporation) 
or Clampfit software (Molecular Devices). All values quoted in this work are based on 
the average of at least three separate recordings.  
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Supporting Figures and Tables 
 
 
 
 
Table S1. Mutations accumulated during the directed evolution rounds of the ClyA-SS 
gene. 
 
Round Name Clone  ID Sequence  changes  relative  to    ClyA-WT 
0 ClyA-SS dSClyA C87S,  C285S 
3  3ClyA1 C87S,  F166Y,  K230R,  C285S 
3  3ClyA2 Q73R,  F166Y,  C285S 
3  3ClyA3 Q33R,  Q56H,  C87S,  D122G,  C285S 
4  4ClyA1 l4T,  N128S,  S145I,  C285S 
4  4ClyA2 S110I,  C285S,  F166Y,  T223A 
4  4ClyA3 T39I,  C285S,  F166Y,  K230R 
4 ClyA-CS 4ClyA4 L99Q,  E103G,  F166Y,  C285S,  K294R 
4  4ClyA5 l4T,  Q73R,  C285S 
4  4ClyA6 Q73R,  F166Y,  C285S 
5  5ClyA1 C87A,  L99Q,  E103G,  C285S,  F166Y,  N220S,  Q289R,  K294R,  
H307Y 
5  5ClyA2 C87A,  L99Q,  E103G,  C285S,  F166Y,  Q289R,  K294R,  H307Y 
5 ClyA-AS 5ClyA3 C87A,  L99Q,  E103G,  C285S,  F166Y,  I203V,  K294R,  H307Y 
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Table S2: primers table. N stands for A, G, C, or T; S is G or C, thus NNS codon 
encodes for the full set of amino acids. 
Name Sequence 
87NNS GAAGCTACCCAAACGGTTTACGAATGGNNSGGTGTGGTTACCCAGCT
GCTG 
T7 
promoter 
TAATACGACTCACTATAGGG 
T7 
terminator 
GCTAGTTATTGCTCAGCGG 
87C GTTTACGAATGGTGTGGTGTGGTTACCCAG 
285C CGCTGCTGATATTCATTACAGGTATTAATCATTTTC 
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Figure S1. Characterization of purified ClyA monomers. (a) Solubility of purified ClyA 
monomers examined by 4-20% acrylamide BN-PAGE. Equal amounts (40 µg) of 
purified ClyA monomers (no detergent) were supplemented with ~10% glycerol and 1x 
of NativePAGETM Running Buffer and 1x Cathode Buffer Additive (InvitrogenTM) and 
loaded in each lane: Lane 1: markers, Lane 2: ClyA-WT, Lane 3: ClyA-SS, Lane 4: 
ClyA-CS, Lane 5: ClyA-AS. (b) Overexpression of ClyA variants. Equal amounts of 
bacterial pellets derived from overnight cultures overexpressing ClyA variants were 
resuspended to ~100 mg/mL concentration and disrupted by sonication followed by 
centrifugation at 20,000g for 10 min (4ºC). 20 Pl of the supernatant containing the 
soluble fraction of ClyA proteins were loaded on lanes 2, 4, 6 and 8 of a 12% 
S18 
 
acrylamide SDS-PAGE. The lysate pellets were brought to the original volume by 
adding a solution containing 15 mM, Tris.HCl pH 7.5, 150 mM NaCl and 2% SDS w/v. 
20 Pl of such solution were loaded on lanes 3, 5, 7 and 9 of the same 12% acrylamide 
SDS-PAGE.  Therefore, Lane 1: protein marker, Lanes 2 and 3: ClyA-SS supernatant 
and pellet fractions, respectively; Lanes 4 and 5: ClyA-WT supernatant and pellet 
fractions, respectively; Lane 6 and 7: ClyA-CS supernatant and pellet fractions, 
respectively; and Lane 8 and 9: ClyA-AS supernatant and pellet fractions, respectively. 
(c) Hemolytic assays. ClyA monomers (0.6 µM) were incubated with 100 Pl of 1% horse 
erythrocytes suspension (110 Pl final volume) and the decrease of turbidity was 
measured at 650 nm (OD650nm). ClyA-WT is shown as a thick grey line, ClyA-SS as a 
thick black line, ClyA-CS as a thin black line and ClyA-AS as a dashed line. d) The rates 
of hemolysis (calculated as the inverse of the time to reach 50% of turbidity) plotted 
against protein concentration ClyA-WT (diamonds, thick grey line), ClyA-SS (squares, 
thick black line), ClyA-AS (circles, dashed line) and ClyA-CS (triangles, thin black line). 
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Figure S2. Examples of the screening of ClyA variants oligomerization using 4-20% 
acrylamide BN-PAGE. (a) Round 4. Lane 1, 2: ClyA-CS, lane 3 and 4: 4ClyA5, lane 5 
and 6: 4ClyA3, lane 7 and 8: 4ClyA1, lane 9 and 10: 4ClyA2, lane 11 and 12: 4ClyA6. 
Samples were prepared as explained in Figure S1a supplemented with 0.05% (even 
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lane number) or 0.1% (odd lane numbers) SDS. SDS was used to counter the 
“smearing”   effect   of   large   quantity   of   DDM   in   the   samples.   (b) Round 5. Lane 1, 2: 
5ClyA2, lane 3: 5ClyA1, lane 4: ClyA-AS. Samples were supplemented with 0.05% 
SDS. Oligomerization was triggered by the addition of 1% DDM and ClyA variants were 
partly purified by Ni-NTA affinity chromatography as described in methods. (c) BN-
PAGE showing the different ClyA-CS bands extracted from preparative gels developed 
by Coomassie staining (Figure 2a).  Lane 1: Protein ladder, lane 2: ClyA-CS monomers 
pre-incubated in 0.5% DDM, Lane 3 ClyA-CS pores extracted from the lowest band 
mainly corresponding to Type I ClyA-CS, lane 4: ClyA-CS pores extracted from the 
second lowest ClyA band mainly corresponding to Type II ClyA-CS. d) BN-PAGE 
showing the ClyA-CS bands extracted from preparative (Figure 2a) gels developed by 
silver staining. Lane 1: Molecular marker, Lane 2: ClyA-CS monomers pre-incubated in 
0.5% DDM, Lane 3 ClyA-CS oligomers extracted from the lowest band mainly 
corresponding to Type I ClyA-CS, lane 4: ClyA-CS oligomers extracted from the second 
lowest ClyA band mainly corresponding to Type II ClyA-CS. Lane 5: ClyA-CS oligomers 
extracted from the third lowest ClyA band mainly corresponding to Type III ClyA-CS. 
ClyA-CS oligomers were extracted in 15 mM Tris.HCl pH 7.5, 150 mM NaCl containing 
0.5% DDM and incubated in the same buffer for 30 min prior loading into the gels. 
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Figure S3. Electrical properties of evolved ClyA-CS nanopores. (a) Current recording of 
Type I ClyA-CS at -150 mV (left current trace) and after switching the potential to +90 
mV (right current trace). (b) Current recording of Type III ClyA-CS showing the 
permanent closing of the pore at -35 mV. Reversing the potential to positive and 
negative potentials (red asterisks) did not restore the open pore current. (c) HT current 
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blockades to Type I (top), Type II (middle) and Type III (bottom) ClyA-CS at -35 mV. 
Type I and II ClyA-CS open pore currents are shown by a red arrow. The current traces 
were recorded at a sampling rate of 50 kHz with an internal low-pass Bessel filter set at 
10 kHz. For presentation purposes, the current traces were further filtered using a digital 
Gaussian low-pass filter with a 2 kHz cutoff. Recordings were carried out in 15 mM 
Tris.HCl, pH 7.5, 150 mM NaCl, 28°C and in presence of 20 nM HT. 
 
 
 
Figure S4. HT current blockades to evolved ClyA-CS nanopores. Voltage dependence 
of the duration (dwell time, a), residual current (IRES%, b) and open pore current (IO, c) of 
HT current blockades to Type I (red) and Type II (blue) ClyA-CS. The large variation of 
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HT blockade dwell times to both Type I and Type II ClyA (a) might be explained by the 
existence of ClyA nanopores with different folded states (Additional Discussion). (d) HT 
current blockades to a Type I ClyA-CS nanopore at -150 mV showing one of the three-
recorded cases where a ClyA-CS nanopore transiently switched between two states 
with different affinity for HT. The inset shows the expanded view where a 4 pA change 
in the open pore current (from IO to IO’)  defines the transition between the two substates 
of the pore. Traces were recorded in 15 mM Tris.HCl, pH 7.5, 150 mM NaCl, in 
presence of 20 nM HT, at a sampling rate of 50 kHz with an internal low-pass Bessel 
filter set at 10 kHz. Each plotted value corresponds to the average determined using at 
least 3 different single channels. Errors are given as standard deviations. 
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Figure S5. Typical HT current blockades on Type I ClyA-CS at -150 mV showing 
“spike”  current  signatures.  The red asterisks indicate a current spike. Recordings were 
carried out in 15 mM Tris.HCl, pH 7.5, 150mM NaCl in presence of 20 nM HT. The 
traces were filtered with a Gaussian low-pass filter with 10,000 Hz cutoff frequency and 
sampled at 50,000 Hz.  
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Figure S6. Typical HT current blockades to Type I (left) and Type II (right) ClyA-CS at 
increasing negative applied potentials (from top to bottom). The current traces were 
recorded at a sampling rate of 50 kHz with an internal low-pass Bessel filter set at 10 
kHz. For presentation purposes, the current traces were further filtered using a digital 
Gaussian low-pass filter with a 2 kHz cutoff. Recordings were performed in 15 mM 
Tris.HCl, pH 7.5, 150mM NaCl and 28°C in presence of 10-20 nM HT. 
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Figure S7. Typical dwell time analysis for HT current blockades to Type I (left) and 
Type II (right) ClyA-CS at increasing negative applied potentials (from top to bottom). 
The graphs show single exponential fits (red lines) to cumulative distributions (blue 
lines) of the collected event lifetimes. Recordings were performed in 15 mM Tris.HCl, 
pH 7.5, 150mM NaCl and 28°C in presence of 10-20 nM HT. 
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